Supreme Court Denies Certiorari in Actavis Laboratories v. Nalproprion Pharmaceuticals
By EsqSocial Corporation 01/06/20
In the Supreme Court's recent clarifying campaign through the Federal Circuit's U.S. patent law jurisprudence, one section of the statute, 35 U.S.C. ยง112(a) has been noticeably left unscathed. Indeed, avoidance of this statutory section continues a...
By: McDonnell Boehnen Hulbert & Berghoff LLP